Amelie Bonnefond studied agronomy, food processing, and management (2004–2007) at the Montpellier SupAgro, Montpellier National Superior School of Agronomy, Montpellier, France, where she obtained a Diploma degree of agronomist (5‐year higher education degree in agronomy) in 2007. In parallel, she graduated in human biology and health at the Montpellier II University, Montpellier, France, where she got an M.S. degree, in 2007, at the INSERM Unit U847, Institute of Research in Biotherapy, Montpellier, France. From 2007 to 2010, Bonnefond prepared a Ph.D. degree at the CNRS Unit 8199, Lille, France. She has subsequently been a Postdoc Fellow in the same laboratory, since 2012. She currently works as the Head of the Next‐Generation Sequencing Development and Optimization Group (from capture and massively parallel sequencing to bioinformatics analyses). Her own research is focused on the contribution of rare genetic events to the risk of type 2 diabetes and obesity. In 2011, Bonnefond was a Postdoc Researcher at the EA Unit 4373, Lorraine University, Nancy, France. She worked on the genetics of cellular adhesion molecules and associated quantitative traits, in the post‐GWAS era. In 2012, Bonnefond was a Visiting Postdoc Researcher at the INSERM Unit 695, Paris, France, where she studied the genetics of micro‐ and macrovascular complications (and related traits) of type 2 diabetes. To date, she has published more than fifty articles in peer‐reviewed scientific journals including Nature, Nature Genetics, Trends Molecular Medicine, Journal of Clinical Investigation, and Journal of Biological Chemistry, Diabetes, and Diabetologia.
Biography Updated on 9 December 2013